HOXC6 and prostate cancer: Unlike AR, whose binding landscape has been documented by ChIP-seq analyses in prostate cancer cell lines14, ChIP-seq data for HOXC6 and NKX2-2 are only available in LoVo cell15, which is a colon adenocarcinoma cancer cell line.